In support of this idea of a kidney-brain axis centered on CD2AP is the recent and exciting finding that α-synuclein accumulates in the kidney of CKD patients (17 out of 20 patients) and Lewy body diseases (10 out of 11 patients) [220]. The gene discussed is CD2AP; the disease is chronic kidney disease.